TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Recipharm AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 397,890 | 180,237 | 8,203,611 |
Financial expenses | 2,290,937 | 1,190,868 | 398,151 |
Earnings before taxes | -14,091 | 57,304 | 369,394 |
EBITDA | -117,878 | -180,787 | 1,445,782 |
Total assets | 19,719,153 | 12,628,971 | 16,037,086 |
Current assets | 2,656,132 | 1,815,273 | 4,488,172 |
Current liabilities | 1,412,956 | 1,209,238 | 2,491,856 |
Equity capital | 12,017,706 | 5,138,472 | 5,451,014 |
- share capital | 33,785 | 36,762 | 25,125 |
Employees (average) | 67 | 64 | 7,857 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 60.9% | 40.7% | 34.0% |
Turnover per employee | 5,939 | 2,816 | 1,044 |
Profit as a percentage of turnover | -3.5% | 31.8% | 4.5% |
Return on assets (ROA) | 11.5% | 9.9% | 4.8% |
Current ratio | 188.0% | 150.1% | 180.1% |
Return on equity (ROE) | -0.1% | 1.1% | 6.8% |
Change turnover | 232,252 | -7,868,090 | 2,676,702 |
Change turnover % | 140% | 48% | |
Chg. No. of employees | 3 | -7,793 | 2,541 |
Chg. No. of employees % | 5% | 48% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.